Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare haematological malignancy
derived from the precursors of plamacytoid dendritic cells, with an aggressive clinical course …

Myeloid sarcoma (MS), also termed extramedullary acute myeloid leukemia, extramedullary
myeloid tumor, and granulocytic sarcoma or chloroma, is a rare manifestation that is …

The objective of this study was to evaluate the clinical features, prognostic factors, and
efficacy of treatments in patients with blastic plasmacytoid dendritic cell neoplasm with a …

Myeloid sarcoma (MS) is a rare neoplasm whose knowledge is largely based on case
reports and/or technically dated contributions. Ninety-two MSs in adulthood with clinical data …

Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease
characterized by malignant proliferation of a contingent blastic plasmacytoid dendritic cell …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a very rare disease that currently
lacks genomic and genetic biomarkers to assist in its clinical management. We performed …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an extremely rare tumour, which
usually affects elderly males and presents in the skin with frequent involvement of the bone …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare disease of controversial
origin recently recognized as a neoplasm deriving from plasmacytoid dendritic cells (pDCs) …

SESSION I neoplasms, although the pathogenesis may be analogous, with a common
clonal origin in both settings. 24-26 BPDCN is characterized by a diffuse and …

We sought to clarify the role of high-dose chemotherapy followed by autologous
hematopoietic stem cell transplantation (auto-HSCT) and allogeneic hematopoietic stem cell …